Related Experiment Videos
Histopathological study of human cisplatin nephropathy
Toxicologic Pathology
|January 1, 1986
Summary
Cisplatin therapy can cause kidney damage, including tubular degeneration and regenerative changes. Specific histological findings like enlarged nuclei and collecting duct hyperplasia indicate renal injury, but platinum levels don't correlate with kidney function impairment.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Cisplatin is a widely used chemotherapy agent.
- Cisplatin can induce nephrotoxicity, a significant clinical concern.
- Understanding cisplatin-induced kidney damage is crucial for patient management.
Purpose of the Study:
- To investigate the morphological changes in human kidneys following cisplatin therapy.
- To identify specific histological markers of cisplatin-induced renal injury.
- To explore the relationship between platinum concentration and renal function impairment.
Main Methods:
- Histological examination of kidneys from ten autopsy cases with impaired renal function post-cisplatin therapy.
- Electron microscopy was used in one case with high-dose cisplatin exposure.
- Analysis of platinum concentration in autopsy organs and biopsy samples.
Main Results:
- Observed lesions included degeneration, necrosis, and regeneration in proximal tubules, distal tubules, and collecting ducts.
- Specific findings indicative of cisplatin renal injury were enlarged, pleomorphic nuclei in regenerated cells and collecting duct hyperplasia.
- No correlation was found between kidney platinum concentration and the degree of renal function impairment.
Conclusions:
- Cisplatin therapy causes characteristic morphological changes in the human kidney.
- Specific histological features can identify cisplatin-induced renal injury.
- Kidney platinum concentration does not reliably predict the extent of cisplatin nephrotoxicity.